Month: May 2025

VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) — Argo Living Soils Corp. (CSE: ARGO) (OTCQB: ARLSF) (FSE: 94Y0) (“Argo” or the “Company”) is pleased to announce it has entered into a research and development (R&D) agreement with Graphene Leaders Canada (GLC) Inc., an Alberta-based leader in high-quality dispersions of graphene and carbon nanomaterials, to develop a graphene nanoplatelet (GNP) additive for ready-mix concrete. This collaboration, formalized through a Phase 1 project proposal, marks a significant step in Argo’s expansion into the green concrete market through its subsidiary, Argo Green Concrete Solutions Inc., leveraging bio-graphene technology to create stronger, more sustainable concrete products. The North American ready-mix concrete market was valued at approximately USD...

Financial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern Time CARMEL, Ind., May 05, 2025 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report financial results for its first quarter 2025, for the period ended March 31, 2025, on Monday, May 12, 2025, before market open. The Company has scheduled a conference call for the same day, Monday, May 12, 2025, at 9:00 am ET to review the results. Conference Call Details Date and Time: Monday, May 12, 2024, at 9:00am ET Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available in the Investor Relations...

Offers Flexible, Cost-Effective Networking Option for Water and Gas Utilities by Eliminating the Need for Expensive Tower-based or Utility Pole Mounted Infrastructure LIBERTY LAKE, Wash., May 05, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, unveils its new Solar Battery Access Point (Solar Battery AP), a solar-powered, battery-operated device to provide reliable network connectivity in areas where traditional mesh networks are not available. The Solar Battery AP combines Itron’s decades of experience building battery-powered devices and field-proven Intelligent Connectivity into a form-factor that will revolutionize networking for the gas and water industry. Available in North America in the second half of 2025, the Itron Solar Battery AP will...

Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports that it has received notice from the U.S. National Highway Traffic Safety Association (NHTSA) for the approval of its BreathLogix “Workplace Series” (WS) alcohol breathalyzer. The BreathLogix WS alcohol screening device (see Figure 1) was recently evaluated by the Volpe Transportation Systems Center and determined to meet the United States Department of Transportation (USDOT) model specifications for breath alcohol screening devices (ASD). The BreathLogix WS will be added to the U.S. Federal Register Conforming Products List (CPL)...

Company continues to expand global IP coverage and claims to major markets, now extending to June 2040  HOUSTON, May 05, 2025 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, today announced the U.S. Patent and Trademark Office (USPTO) has granted two additional U.S. patents with claims covering Annamycin. U.S. patent number 12,257,261 titled, “Preparation of Preliposomal Annamycin Lyophilizate”, has claims covering methods of making liposomal Annamycin and U.S. patent 12,257,262 titled “Method of Reconstituting Liposomal Annamycin“, has claims covering methods of making liposomal Annamycin suspension. Both patents have a base patent term currently extending until June...

FORT LAUDERDALE, Fla., May 05, 2025 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today reiterated guidance for the first quarter of 2025. Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “Following our recent uplisting to Nasdaq, we remain very pleased with the growth trajectory of our business as we conclude the first quarter of 2025 and enter the second quarter. We believe that we are well-positioned to maintain this momentum and achieve new and impactful milestones throughout 2025.” The Company reiterated:14 SSi Mantra surgical robotic systems were installed during the first...

VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce the appointment of Dr. David M. Kideckel, Ph.D., MBA, as Chief Financial Officer (CFO), subject to approval from the TSX Venture Exchange (“TSXV”). Dr. Kideckel brings nearly two decades of experience in life sciences, capital markets, and corporate advisory, with a proven track record of assisting public and private healthcare companies scale their operations and unlock shareholder value. He is the Founder and Principal of the Kideckel Advisory Group Inc., which provides fractional CFO, Chief Business Officer (CBO), and capital markets services...